Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-01-26 @ 11:34 AM
Study NCT ID:
NCT02123966
Status:
TERMINATED
Last Update Posted:
2018-07-24
First Post:
2014-04-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07
Start Date Type:
ACTUAL
Primary Completion Date:
2016-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-23
First Submit QC Date:
None
Study First Post Date:
2014-04-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-11
Results First Submit QC Date:
None
Results First Post Date:
2018-07-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-26
Last Update Post Date:
2018-07-24
Last Update Post Date Type:
ACTUAL